Investigating molecular interactions between human transferrin and resveratrol through a unified experimental and computational approach: Role of natural compounds in Alzheimer’s disease therapeutics

Resveratrol inhibits calcium oxalate crystal growth, reduces adhesion to renal cells and induces crystal internalization into the cells, but promotes crystal aggregation

“…It is also known as a phytoalexin that serves as a plant-derived anti-oxidant and antibiotic ( Recalde et al, 2020 ; Song et al, 2021 ; Wang et al, 2022a ). Other health benefits and therapeutic potentials of resveratrol and its derivatives have been widely recognized in various diseases, including diabetes ( Park et al, 2016 ; Xu et al, 2022 ), cardiovascular diseases ( Lu et al, 2019 ; Xia et al, 2017 ), Alzheimer's disease ( Han et al, 2023 ; Khan et al, 2023 ), and cancers ( Arif et al, 2024 ; Dariya et al, 2023 ). Resveratrol also shows anti-inflammatory effects in mice with colitis and mucosal damage ( Zhang et al, 2023 ).…”